SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-21-144719
Filing Date
2021-11-30
Accepted
2021-11-30 08:10:12
Documents
13
Period of Report
2021-11-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2133053d2_8k.htm   iXBRL 8-K 24739
2 EXHIBIT 99.1 tm2133053d2_ex99-1.htm EX-99.1 10451
  Complete submission text file 0001104659-21-144719.txt   213247

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA hepa-20211130.xsd EX-101.SCH 3019
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE hepa-20211130_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hepa-20211130_pre.xml EX-101.PRE 22355
6 EXTRACTED XBRL INSTANCE DOCUMENT tm2133053d2_8k_htm.xml XML 3690
Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837
Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000
Hepion Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)

IRS No.: 462783806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36856 | Film No.: 211458337
SIC: 2834 Pharmaceutical Preparations